CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses

CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. 2021-09-27 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyvaccineSARS-CoV-2nucleicacidcoronavirusCOVID-19epidemiologyCanadaseasonalityGenomic surveillancegenomicsequencingvariantsconcernpublic healthsurveillancesocialdistancingphysical distancinginfluenzanonpharmaceuticalinterventionsNPImeaslestravel healthmeasles eliminationvaccinationinfectious diseasesknowledgebrokeringvaccineacceptancevaccine hesitancyinterventionsevaluationTailoringImmunizationProgrammesTIPCCDR CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory VirusesHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr.html CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory VirusesHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc.html Vaccine against SARS-CoV-2: Challenges and considerationsHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/sars-cov-2-vaccine-challenges-considerations.html Vaccine against SARS-CoV-2: Challenges and considerationsHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/defis-considerations-vaccin-sras-cov-2.html Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/seasonal-patterns-coronavirus-respiratory-viruses.html Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/modeles-saisonniers-coronavirus-virus-respiratoires.html Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concernHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/sars-cov-2-variants.html Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concernHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/variants-sras-cov-2.html Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in CanadaHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/epidemiologic-seasonal-influenza-covid-19-shutdowns.html Measles surveillance in Canada, 2019HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/measles-annual-surveillance-report-2019.html Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in CanadaHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/epidemiologiques-grippe-saisonniere-fermetures-covid-19.html Measles surveillance in Canada, 2019HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/rapport-annuel-surveillance-rougeole-2019.html Knowledge brokering on infectious diseases for public healthHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/public-health-knowledge-brokering.html Knowledge brokering on infectious diseases for public healthHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/sante-publique-courtage-connaissances.html Designing tailored interventions to address barriers to vaccinationHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/vaccine-hesitancy.html Designing tailored interventions to address barriers to vaccinationHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/hesitation-vaccination.html How COVID-19 vaccines will be regulated for safety and effectivenessHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/covid-19-vaccine-safety-effectiveness.html How COVID-19 vaccines will be regulated for safety and effectivenessHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/vaccin-covid-19-innocuite-efficacite.html

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Data and Resources

Similar records